Interstitial Lung Disease (ILD)
Click on the trial below for more information.
Sponsor:Insmed Incorporated Information provided by (Responsible Party):Insmed Incorporated The main objective of this study is to evaluate the efficacy of ALIS (amikacin liposome inhalation suspension) + background regimen (azithromycin [AZI] + …
Sponsor:AstraZeneca Information provided by (Responsible Party):AstraZeneca This is a variable length study to evaluate the efficacy and safety of budesonide/glycopyrronium/formoterol inhaler in adults and adolescents with severe asthma inadequately controlled …
Sponsor:Sanofi Collaborator:Regeneron Pharmaceuticals Information provided by (Responsible Party):Sanofi Primary Objective: To evaluate the efficacy of dupilumab administered every 2 weeks in patients with moderate-or severe Chronic Obstructive Pulmonary Disease (COPD) …